Volume 8, Issue 2, April 2021

Neuro-Oncology Practice in 2021: Covid-19, telemedicine, and beyond

• Extract
• View article

Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic

• Abstract
• View article

Cognitive impact of lower-grade gliomas and strategies for rehabilitation

• Abstract
• View article

Analysis of the quality of meningioma education resources available on the Internet

• Abstract
• View article
• Supplementary data

Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module

• Abstract
• View article

Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients

• Abstract
• View article
• Supplementary data

Cognitive complaints in brain tumor patients and their relatives’ perspectives

• Abstract
• View article

Caregiver perceptions of end-of-life care in patients with high-grade glioma

• Abstract
• View article

Understanding sleep disturbance in the context of malignant brain tumors: a qualitative analysis

• Abstract
• View article
• Supplementary data

Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas

• Abstract
• View article
• Supplementary data

Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status

• Abstract
• View article
• Supplementary data

FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma

• Abstract
• View article
• Supplementary data

Predictors of outcome in pleomorphic xanthoastrocytoma

• Abstract
• View article
• Supplementary data

Forthcoming Meetings

• Extract
• View article